TipRanks
Advertisement
Advertisement

DE:7SS Stock Latest News

Brii Biosciences Issues New Share Options and RSUs Under 2023 Incentive Schemes
Company AnnouncementsBrii Biosciences Issues New Share Options and RSUs Under 2023 Incentive Schemes
2d ago
Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance
PremiumCompany Announcements
Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance
2M ago
Brii Biosciences Sets August Board Meeting to Approve 2026 Interim Results
PremiumCompany Announcements
Brii Biosciences Sets August Board Meeting to Approve 2026 Interim Results
2M ago
Brii Biosciences Posts Promising Phase 2b Hepatitis B Data but Elebsiran Future Clouded by Arbitration
PremiumCompany Announcements
Brii Biosciences Posts Promising Phase 2b Hepatitis B Data but Elebsiran Future Clouded by Arbitration
3M ago
Brii Biosciences Launches HK$60 Million Share Buy-back to Signal Confidence and Unlock Value
PremiumCompany Announcements
Brii Biosciences Launches HK$60 Million Share Buy-back to Signal Confidence and Unlock Value
4M ago
Brii Biosciences Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany AnnouncementsBrii Biosciences Shareholders Approve All Resolutions at 2026 AGM
4M ago
Brii Biosciences Warns Hepatitis B Drug Program at Risk Amid Vir Arbitration
Premium
Company Announcements
Brii Biosciences Warns Hepatitis B Drug Program at Risk Amid Vir Arbitration
5M ago
Brii Biosciences Data Backs Shorter NRTI Use in Next-Generation HBV Therapies
Premium
Company Announcements
Brii Biosciences Data Backs Shorter NRTI Use in Next-Generation HBV Therapies
6M ago
Brii Biosciences Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
PremiumCompany Announcements
Brii Biosciences Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
6M ago
Brii Biosciences Launches Arbitration Against Vir Over Hepatitis B Drug Manufacturing Rights
PremiumCompany Announcements
Brii Biosciences Launches Arbitration Against Vir Over Hepatitis B Drug Manufacturing Rights
6M ago
Brii Biosciences Narrows 2025 Loss as Costs Fall and Revenue Emerges
PremiumCompany Announcements
Brii Biosciences Narrows 2025 Loss as Costs Fall and Revenue Emerges
7M ago
Brii Biosciences Confirms 2025 PFIC Status, Issues Tax Statement for U.S. Holders
PremiumCompany Announcements
Brii Biosciences Confirms 2025 PFIC Status, Issues Tax Statement for U.S. Holders
7M ago
Brii Biosciences Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsBrii Biosciences Sets March 2026 Board Meeting to Approve 2025 Annual Results
7M ago
Brii Biosciences Updates Nomination Committee Terms
Premium
Company Announcements
Brii Biosciences Updates Nomination Committee Terms
11M ago
Brii Biosciences Reports Promising Results from Phase 2 HBV Study
Premium
Company Announcements
Brii Biosciences Reports Promising Results from Phase 2 HBV Study
11M ago
Brii Biosciences’ Phase 2 Study Shows Promise in Hepatitis B Treatment
PremiumCompany Announcements
Brii Biosciences’ Phase 2 Study Shows Promise in Hepatitis B Treatment
11M ago
Brii Biosciences Grants 600,000 Share Options to Enhance Strategic Advisory Services
PremiumCompany Announcements
Brii Biosciences Grants 600,000 Share Options to Enhance Strategic Advisory Services
11M ago
Brii Biosciences Grants Share Options and RSUs to Align Employee Interests
PremiumCompany Announcements
Brii Biosciences Grants Share Options and RSUs to Align Employee Interests
12M ago
Brii Biosciences Revises Fund Allocation to Boost Therapeutic Programs
PremiumCompany Announcements
Brii Biosciences Revises Fund Allocation to Boost Therapeutic Programs
1y ago
Brii Biosciences Advances Hepatitis B Program Amid Financial Adjustments
PremiumCompany AnnouncementsBrii Biosciences Advances Hepatitis B Program Amid Financial Adjustments
1y ago
Brii Biosciences Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
Brii Biosciences Schedules Board Meeting to Review Interim Results
1y ago
Brii Biosciences Partners with Joincare for BRII-693 Development in Greater China
Premium
Company Announcements
Brii Biosciences Partners with Joincare for BRII-693 Development in Greater China
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >